Food Regime for Phenylketonuria: Presenting Complications and Possible Solutions

References

• Macleod EL, Ney DM. Nutritional management of phenylketonuria. Ann Nestle Eng. 2010;68(2):58–69. doi:10.1159/000312813
   PubMedGoogle Scholar
• Burnett JR. Sapropterin dihydrochloride (Kuvan/phenoptin), an orally active synthetic form of BH4 for the treatment of phenylketonuria. IDrugs. 2007;10(11):805–813.
   PubMedGoogle Scholar
• Acosta PB, Matalon KM. Nutrition management of patients with inherited disorders of aromatic amino acid metabolism. In: Nutrition Management of Patients with Inherited Metabolic Disorders Boston. Jones and Bartlett Publishers; 2010;119–174.
   Google Scholar
• Blau N, Van Spronsen FJ, Levy HL. Phenylketonuria. Lancet. 2010;376(9750):1417–1427.
   PubMed Web of Science ®Google Scholar
• Channon S, German E, Cassina C, Lee P. Executive functioning, memory, and learning in phenylketonuria. Neuropsychology. 2004;18(4):613.
   PubMed Web of Science ®Google Scholar
• Ho G, Christodoulou J. Phenylketonuria: translating research into novel therapies. Trans Pediatr. 2014;3(2):49.
   PubMedGoogle Scholar
• Marcdante K, Kliegman RM. Nelson Essentials of Pediatrics e-Book. Elsevier Health Sciences; 2014.
   Google Scholar
• Rocha JC, MacDonald A. Dietary intervention in the management of phenylketonuria: current perspectives. Pediatric Health Med Ther. 2016;7:155–163.
   PubMed Web of Science ®Google Scholar
• Scriber C. Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. The metabolic and molecular bases of inherited disease; 2001:1667–1724.
   Google Scholar
• Al Hafid N, Christodoulou J. Phenylketonuria: a review of current and future treatments. Transl Pediatr. 2015;4(4):304–317. doi:10.3978/j.issn.2224-4336.2015.10.07
   PubMed Web of Science ®Google Scholar
• Giovannini M, Verduci E, Salvatici E, Paci S, Riva E. Phenylketonuria: nutritional advances and challenges. Nutr Metab. 2012;9(1):7. doi:10.1186/1743-7075-9-7
   Google Scholar
• Habib A, Fallahzadeh MH, Kazeroni HR, Ganjkarimi AH. Incidence of phenylketonuria in Southern Iran. Iran J Med Sci. 2010;35(2):137–139.
   Google Scholar
• Azen CG, Koch R, Friedman EG, et al. Intellectual development in 12-year-old children treated for phenylketonuria. Am J Dis Child. 1991;145(1):35–39. doi:10.1001/archpedi.1991.02160010037012
   PubMedGoogle Scholar
• Williams RA, Mamotte CD, Burnett JR. Phenylketonuria: an inborn error of phenylalanine metabolism. Clin Biochem Rev. 2008;29(1):31–41.
   PubMedGoogle Scholar
• Ramsay J, Morton J, Norris M, Kanungo S. Organic acid disorders. Ann Transl Med. 2018;6(24):472. doi:10.21037/atm.2018.12.39
   PubMed Web of Science ®Google Scholar
• Abadie V, Berthelot J, Feillet F, et al. Neonatal screening and long-term follow-up of phenylketonuria: the French database. Early Hum Dev. 2001;65(2):149–158. doi:10.1016/S0378-3782(01)00223-7
   PubMed Web of Science ®Google Scholar
• Dhondt J, Farriaux J, Briard M, Boschetti R, Frezal J. Neonatal screening in France. Screening. 1993;2(2–3):77–85. doi:10.1016/0925-6164(93)90021-A
   Google Scholar
• Acs E, Kovacs Z, Matuz J. Bread from corn starch for dietetic purposes I. Structure Formation. Cereal Res Commun. 1996;24:441–449.
   Web of Science ®Google Scholar
• Castañeda MT, Adachi O, Hours RA. Reduction of l-phenylalanine in protein hydrolysates using l-phenylalanine ammonia-lyase from Rhodosporidium toruloides. J Ind Microbiol Biotechnol. 2015;42(10):1299–1307. doi:10.1007/s10295-015-1664-z
   PubMed Web of Science ®Google Scholar
• Amiri-Rigi A, Mohammadi M, Emam-Djomeh Z, Mohammadifar M. The effect of type of enzyme and activated carbon concentration on phenylalanine removal from milk. Iran J Nutr Sci Food Technol. 2012;7(1):1–9.
   Google Scholar
• Capobiango M, Lopes DCF, Carreira RL, de Oliveira Afonso W, Segall SD, Silvestre MPC. Optimization of enzyme assisted processes for extracting and hydrolysing corn proteins aiming phenylalanine removal. Int J Food Eng. 2007;3(6). doi:10.2202/1556-3758.1268
   Web of Science ®Google Scholar
• Carreira RL, Silva MR, Starling ALP, Aguiar MJ, Januario JN, Silvestre MP. Association of two enzymes for obtaining low phenylalanine protein hydrolysates from wheat flour. Int J Food Eng. 2008;4(7). doi:10.2202/1556-3758.1544
   Web of Science ®Google Scholar
• Clemente A. Enzymatic protein hydrolysates in human nutrition. Trends Food Sci Technol. 2000;11(7):254–262. doi:10.1016/S0924-2244(01)00007-3
   Web of Science ®Google Scholar
• Kitagawa T, Owada M, Aoki K, et al. Treatment of phenylketonuria with a formula consisting of low-phenylalanine peptide. Enzyme. 1987;38(1–4):321–327. doi:10.1159/000469222
   PubMedGoogle Scholar
• Lara MG, Izumi C, Greene LJ, Vilela L, Freitas O. Preparation and scaling up of a low phenylalanine enzymatic hydrolysate of bovine whey proteins. Rev Bras Ciênc Farm. 2005;41(4):459–466. doi:10.1590/S1516-93322005000400008
   Google Scholar
• Lopes DCF, Delvivo FM, Silvestre MPC. Use of activated carbon for removing phenylalanine from reconstituted skim milk powder hydrolysates. LWT. 2005;38(5):447–453. doi:10.1016/j.lwt.2004.07.021
   Web of Science ®Google Scholar
• Lopes DCF, Delvivo FM, Silvestre MPC. Dietary supplements for phenylketonuria: removing Phe by activated carbon. Nutr Food Sci. 2006. doi:10.1108/00346650610652303
   Google Scholar
• Lopez‐Bajonero L, Lara‐Calderon P, Galvez‐Mariscal A, Velazques‐Arellano A, Lopez‐Munguia A. Enzymatic production of a low‐phenylalanine product from skim milk powder and casemate. J Food Sci. 1991;56(4):938–942. doi:10.1111/j.1365-2621.1991.tb14610.x
   Web of Science ®Google Scholar
• Matalon R, Michals-Matalon K, Bhatia G, et al. Large neutral amino acids in the treatment of phenylketonuria (PKU). J Inherit Metab Dis. 2006;29(6):732–738. doi:10.1007/s10545-006-0395-8
   PubMed Web of Science ®Google Scholar
• Moszczynski P, Idziac J. Preparation of enzymatic hydrolysates of casein depleted in phenylalanine. Appl Biochem Microbiol. 1993;29(3):302–306.
   Google Scholar
• Shehata AE, El-Magdoub MN, Kamal TM, Mohamed HA. enzymatic preparation of low-phenylalanine formula derived from skim milk hydrolysate for phenyl ketonuric patients. Egypt J Med Hum Genet. 2008;9(1):51–71.
   Google Scholar
• Silva VD, De Marco LM, Afonso WO, Lopes DC, Silvestre MP. Comparative study of the immobilization of pancreatin and papain on activated carbon and alumina, using whey as protein substrate. World Appl Sci J. 2007;2:175–183.
   Google Scholar
• Silvestre MP, Da silva MC, de Souza MW, Silva VD, de Aguiar MJ, Silva MR. Hydrolysis degree, peptide profile and phenylalanine removal from whey protein concentrate hydrolysates obtained by various proteases. Int J Food Sci Technol. 2013;48(3):588–595.
   Web of Science ®Google Scholar
• Soares RD, Biasutti EA, Capobiango M, et al. Preparation of enzymatic skim milk hydrolysates with low phenylalanine content. Acta Farmaceutica Bonaerense. 2007;25(3):325.
   Google Scholar
• Soltanizadeh N, Mirmoghtadaie L. Strategies used in production of phenylalanine‐free foods for PKU management. Compr Rev Food Sci Food Saf. 2014;13(3):287–299.
   PubMed Web of Science ®Google Scholar
• National Institutes of Health Consensus Development Panel. National institutes of health consensus development conference statement: phenylketonuria: screening and management, October 16–18, 2000. Pediatrics. 2001;108(4):972–982.
   PubMed Web of Science ®Google Scholar
• Singh RH, Rohr F, Frazier D, et al. Recommendations for the nutrition management of phenylalanine hydroxylase deficiency. Gene Med. 2014;16(2):121–131.
   PubMed Web of Science ®Google Scholar
• Mathias D, Bickel H. Follow-up study of 16 years neonatal screening for inborn errors of metabolism in West Germany. Eur J Pediatr. 1986;145(4):310–312.
   PubMed Web of Science ®Google Scholar
• Missiou‐Tsagaraki S, Soulpi K, Loumakou M. Phenylketonuria in Greece: 12 year’s experience. J Intell Disabil Res. 1988;32(4):271–287.
   Google Scholar
• Õunap K, Lilleväli H, Metspalu A, Lipping-Sitska M. Development of the phenylketonuria screening programme in Estonia. J Med Screen. 1998;5(1):22–23.
   PubMed Web of Science ®Google Scholar
• Smith I, Cook B, Beasley M. Review of neonatal screening programme for phenylketonuria. Br Med J. 1991;303(6798):333–335.
   PubMed Web of Science ®Google Scholar
• Motamedi N, Goodarzi E, Pordanjani SR, et al. Incidence of phenylketonuria in Lorestan province, West of Iran (2006–2016). In. J Pediatr. 2017;5:4713–4721.
   Web of Science ®Google Scholar
• Shoraka HR, Haghdoost AA, Baneshi MR, Bagherinezhad Z, Zolala F. Global prevalence of classic phenylketonuria based on Neonatal Screening Program Data: systematic review and meta-analysis. Clin Exper Pediatr. 2020;63(2):34.
   PubMedGoogle Scholar
• Özalp I, Coşkun T, Tokatli A, et al. Neonatal PKU screening in Turkey: 7 years experience in a developing country. Screening. 1995;4(3):139–147.
   Google Scholar
• Koochmeshgi J, Bagheri A, Hosseini-Mazinani S. Incidence of phenylketonuria in Iran estimated from consanguineous marriages. J Inherit Metab Dis. 2002;25(1):80.
   PubMed Web of Science ®Google Scholar
• Rose AM, Grosse SD, Garcia SP, et al. The financial and time burden associated with phenylketonuria treatment in the United States. Mol Gene Metab Rep. 2019;21:100523.
   PubMed Web of Science ®Google Scholar
• Barden HS, Kessel R, Schuett VE. The costs and benefits of screening for PKU in Wisconsin. Soc Biol. 1984;31(1–2):1–17.
   PubMed Web of Science ®Google Scholar
• LaClair CE, Ney DM, MacLeod EL, Etzel MR. Purification and use of glycomacropeptide for nutritional management of phenylketonuria. J Food Sci. 2009;74(4):E199–E206.
   PubMed Web of Science ®Google Scholar
• Berry HK, Bofinger MK, Hunt MM, Phillips PJ, Guilfoile MB. Reduction of cerebrospinal fluid phenylalanine after oral administration of valine, isoleucine, and leucine. Pediatr Res. 1982;16(9):751–755.
   PubMed Web of Science ®Google Scholar
• Burlina AP, Cazzorla C, Massa P, et al. Large neutral amino acid therapy increases tyrosine levels in adult patients with phenylketonuria: a long-term study. Nutrients. 2019;11(10):2541.
   PubMed Web of Science ®Google Scholar
• Ney D, Gleason S, Van Calcar S, et al. Nutritional management of PKU with glycomacropeptide from cheese whey. J Inherit Metab Dis. 2009;32(1):32–39.
   PubMed Web of Science ®Google Scholar
• Bonnaillie LM, Qi P, Wickham E, Tomasula PM. Enrichment and purification of casein glycomacropeptide from whey protein isolate using supercritical carbon dioxide processing and membrane ultrafiltration. Foods. 2014;3(1):94–109.
   PubMedGoogle Scholar
• Leuzzi V, Pansini M, Sechi E, et al. Executive function impairment in early‐treated PKU subjects with normal mental development. J Inherit Metab Dis. 2004;27(2):115–125.
   PubMed Web of Science ®Google Scholar
• Robinson M, White FJ, Cleary MA, Wraith E, Lam WK, Walter JH. Increased risk of vitamin B12 deficiency in patients with phenylketonuria on an unrestricted or relaxed diet. J Pediatr. 2000;136(4):545–547.
   PubMed Web of Science ®Google Scholar
• Hanley W, Feigenbaum A, Clarke J, Schoonheyt W, Austin V. Vitamin B 12 deficiency in adolescents and young adults with phenylketonuria. Eur J Pediatr. 1996;155(1):S145–S147.
   PubMed Web of Science ®Google Scholar
• Schulpis K, Karikas G, Papakonstantinou E. Homocysteine and other vascular risk factors in patients with phenylketonuria on a diet. Acta Paediatr. 2002;91(8):905–909.
   PubMed Web of Science ®Google Scholar
• Hvas A, Nexo E, Nielsen J. Vitamin B 12 and vitamin B 6 supplementation is needed among adults with phenylketonuria (PKU). J Inherit Metab Dis. 2006;29(1):47–53.
   PubMed Web of Science ®Google Scholar
• Procházková D, Jarkovský J, Vinohradská H, Konečná P, Machačová L, Doležel Z. Controlled diet in phenylketonuria and hyperphenylalaninemia may cause serum selenium deficiency in adult patients: the Czech experience. Biol Trace Elem Res. 2013;154(2):178–184.
   PubMed Web of Science ®Google Scholar
• van Spronsen FJ, Enns GM. Future treatment strategies in phenylketonuria. Mol Genet Metab. 2010;99:S90–S95.
   PubMed Web of Science ®Google Scholar
• Lopes DCF, Bizzotto CS, Carreira RL, Afonso W, Lopes JC, Silvestre MPC. Removal of phenylalanine from protein hydrolysates prepared with rice. J Food Technol. 2008;6(2):57–65.
   Google Scholar
• Etemadian Y, Ghaemi V, Shaviklo AR, Pourashouri P, Mahoonak ARS, Rafipour F. Development of animal/plant-based protein hydrolysate and its application in food, feed and nutraceutical industries: state of the art. J Clean Prod. 2021;278:123219.
   Web of Science ®Google Scholar
• Allaoui A, Gascón S, Benomar S, et al. Protein hydrolysates from fenugreek (Trigonella foenum graecum) as nutraceutical molecules in colon cancer treatment. Nutrients. 2019;11(4):724.
   PubMed Web of Science ®Google Scholar
• Al-Shamsi KA, Mudgil P, Hassan HM, Maqsood S. Camel milk protein hydrolysates with improved technofunctional properties and enhanced antioxidant potential in in vitro and in food model systems. J Dairy Sci. 2018;101(1):47–60.
   PubMed Web of Science ®Google Scholar
• Marcason W. Is there a standard meal plan for phenylketonuria (PKU)? J Acad Nutr Diet. 2013;113(8):1124.
   PubMed Web of Science ®Google Scholar
• Bajaj R, Patel Z, Ambani L, Rao BN, Merchant S. Dietary therapy in a case of phenylketonuria in India. Indian J Pediatr. 1981;48(2):175–178.
   PubMedGoogle Scholar
• Burlina AP, Cazzorla C, Massa P, Loro C, Gueraldi D, Burlina AB. The impact of a slow-release large neutral amino acids supplement on treatment adherence in adult patients with phenylketonuria. Nutrients. 2020;12(7):2078.
   PubMed Web of Science ®Google Scholar
• Nutricia Learning Cerner. Guidelines for the usage of PhenylAde® PheBLOC™. Available from: https://www.nutricialearningcenter.com/globalassets/pdfs/metabolics/phebloc-guidelines_101617.pdf Accessed December 22, 2021.
   Google Scholar
• Pena MJ, De Almeida MF, Van Dam E, et al. Protein substitutes for phenylketonuria in Europe: access and nutritional composition. European Journal of Clinical Nutrition. 2016;70(7):785–789.
   PubMed Web of Science ®Google Scholar
• Inventors: Li Q, Kämpe O. Assignee: NEXTTOBE AB. Recombinant Phe-free proteins for use in the treatment of phenylketonuria. U.S. Patent 10,174,354. 2019 Jan 8.
   Google Scholar
• Bu T, Zhou M, Zheng J, et al. Preparation and characterization of a low-phenylalanine whey hydrolysate using two-step enzymatic hydrolysis and macroporous resin adsorption. LWT. 2020;132:109753.
   Google Scholar
• Pristine Organics Private Limited. Phenylketonuria (PKU)-1, 400 g. Available from: https://pristineorganics.com/product/phenylketonuria-pku/. Accessed December 21, 2021.
   Google Scholar